Abstract
Environmental contributions to the development of childhood obesity may include a suboptimal in utero environment, diabetes and/or obesity in pregnancy, and pre- and postnatal exposure to environmental chemicals, also known as obesogens. Epigenetic modifications may be one mechanism by which exposure to an altered intrauterine milieu or metabolic perturbation may influence the phenotype of the organism much later in life. Epigenetic modifications of the genome provide a mechanism that allows the stable propagation of gene expression from one generation of cells to the next. This chapter highlights our current knowledge of epigenetic gene regulation and the evidence that chromatin remodeling and histone modifications play key roles in adipogenesis and the development of obesity. Epigenetic modifications affecting processes important to glucose regulation and insulin secretion have been described in the pancreatic β-cells and muscle of the intrauterine growth retarded (IUGR) offspring, characteristics essential to the pathophysiology of type 2 diabetes (T2DM). Epigenetic regulation of gene expression contributes to both adipocyte determination and differentiation in in vitro models. The contributions of histone acetylation, histone methylation, and DNA methylation to the process of adipogenesis in vivo remain to be evaluated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dietz WH. Overweight in childhood and adolescence. N Engl J Med. 2004;350:855–7.
Taylor PD, Poston L. Developmental programming of obesity in mammals. Exp Physiol. 2007;92:287–98.
Simmons R. Perinatal programming of obesity. Semin Perinatol. 2008;32:371–4.
Bayol SA, Bigboy SH, Stickland NC. A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. J Physiol. 2005;567:951–61.
Catalano PM. Obesity and pregnancy – the propagation of a viscous cycle? J Clin Endocrinol Metab. 2003;88:3500–6.
Levin BE, Dunn-Meynell AA. Maternal obesity alters adiposity and monoamine function in genetically predisposed offspring. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1087–R93.
Levin BE, Govek E. Gestational obesity accentuates obesity in obesity-prone progeny. Am J Physiol Regul Integr Comp Physiol. 1998;275:R1375–9.
Guo F, Jen K-L. High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol Behav. 2005;57:681–6.
Reifsnyder PC, Churchill G, Leiter EH. Maternal environment and genotype interact to establish diabesity in mice. Genome Res. 2000;10:1568–78.
Bannister AJ, Kouzarides T. Reversing histone methylation. Nature. 2005;436:1103–6.
Bernstein E, Allis CD. RNA meets chromatin. Genes Dev. 2005;19:1635–55.
Mellor J. The dynamics of chromatin remodeling at promoters. Mol Cell. 2005;19:147–57.
Sproul D, Gilbert N, Bickmore WA. The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet. 2005;6:775–81.
Yoshida H, Broaddus R, Cheng W, et al. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition. Cancer Res. 2006;66:889–97.
So K, Tamura G, Honda T, et al. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci. 2006;97:1155–8.
Takahashi T, Shigematsu H, Shivapukas N, et al. Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. Int J Cancer. 2006;118:924–31.
Grady WM, Carethers JM. Genomic and epigenetic instability incolorectal cancer pathogenesis. Gastroenterology. 2008;135:1079–99.
Kafri T, Ariel M, Brandeis M, et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germline. Genes Dev. 1992;6:705–14.
Monk M, Boubelik M, Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extra-embryonic and germ cell lineages during mouse embryo development. Development. 1987;99:371–82.
Cedar H, Bergman Y. Linking DNA methylations and histone modifications: patterns and paradigms. Nat Rev Genet. 2009;10:295–304.
Schubeler D, Lorincz MC, Cimbora DM, et al. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol. 2000;20:9103–12.
Gopalakrishnan S, Van Emburgh BO, Robertson KD. DNA methylation in development and human disease. Mutat Res. 2008;647:30–83.
Costa FF. Non-coding RNAs, epigenetics and complexity. Gene. 2008;410:9–17.
Costa FF. Non-coding RNAs: new players in eukaryotic biology. Gene. 2005;2:83–94.
Kawasaki H, Taira K. Induction of DNA methylation and gene silencing by short interfacing RNAs in human cells. Nature. 2004;431:211–7.
Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science. 2004;305:1289–92.
MacLennan NK, James SJ, Melnyk S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics. 2004;18:43–50.
Fu Q, McKnight RA, Yu X, et al. Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNA-histone H3 positioning in day 0 IUGR rat liver. Physiol Genomics. 2004;20:108–16.
Park JH, Stoffers DA, Nichols RD, et al. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx-1. J Clin Invest. 2008;118:2316–24.
Raychaudhuri N, Raychaudhari S, Thamotharan M, et al. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J Biol Chem. 2008;283:13611–26.
Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to type II diabetes in adulthood in the rat. Diabetes. 2001;50:2279–86.
Stoffers DA, Desai BM, DeLeon DD, et al. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes. 2003;52:734–40.
Qian J, Kaytor ED, Towle HC, et al. Upstream stimulatory factor regulates Pdx-1 gene expression in differentiated pancreatic β-cells. Biochem J. 1999;341:315–22.
Sharma S, Leonard J, Lee S, et al. Pancreatic islet expression of the homeobox factor STF-1 (Pdx-1) relies on an E-box motif that binds USF. J Biol Chem. 1996;271:2294–9.
Li H, Rauch T, Chen ZX, et al. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem. 2006;281:19489–500.
Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 2003;3:89–95.
Kouzarides T. Histone methylation in transcriptional control. Curr Opin Genet Dev. 2002;12:198–209.
Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol. 2008;294:1–9.
Thamotharan M, Shin BC, Suddirikku DT, et al. GLUT4 expression and subcellular localization in the intrauterine growth-restricted adult rat female offspring. Am J Physiol Endocrinol Metab. 2004;288:E935–47.
Ozanne SE, Jensen CB, Storgaard H, et al. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia. 2005;48:547–52.
Fueger PT, Shearer J, Krueger TM, et al. Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice. J Physiol. 2005;562:925–35.
Karnieli E, Armoni M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab. 2008;295:E38–45.
Moreno H, Serrano AL, Santaucia T, et al. Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle. J Biol Chem. 2003;278:40557–64.
Zhang Y, Proenca R, Maffei M, et al. Positional Clonging of the mouse obese gene and its human homologue. Nature. 1994;372:425–31.
Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006;7(12):886–96.
Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783–7.
Billion N, Monteiro MC, Dani C. Developmental origin of adipocytes: new insights into a pending question. Biol Cell. 2008;100(10):563–75.
Moulin K, Truel N, Andre M, et al. Emergence during development of the white-adipose cell phenotype is independent of the brown-adipose cell phenotype. Biochem J. 2001;356:659–64.
Himms-Hagen J, Melnyk A, Zingaretti MC, et al. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am J Physiol Cell Physiol. 2000;279:C670–81.
Green H, Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 1976;7:105–13.
Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4:263–73.
Nakagami H, Morishita R, Maeda K, et al. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb. 2006;13:77–81.
Musri MM, Gomis R, Parrozas M. Chromatin and chromatin-modifying proteins in adipogenesis. Biochem Cell Biol. 2007;85:397–410.
Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci USA. 2006;103:13022–7.
Tang QQ, Otto TC, Lane MD. Commitment of Ch310T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci USA. 2004;101:9607–11.
Schulz TJ, Tseng YH. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev. 2009;20:523–31.
Tseng YH, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 and energy expenditure. Nature. 2008;454(7207):1000–4.
Yeh WC, Cao Z, Classon M, Mc Knight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995;9:168–81.
Tang QQ, Lane MD. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 1999;13:2231–41.
Tang QQ, Otto TC, Lane MD. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA. 2003;100:44–9.
Reichard M, Eick D. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene. 1999;18:459–66.
Wang GL, Shi X, Salisbury E, Sun Y, Albrecht JH, Smith RG, et al. Cyclin D3 maintains growth inhibitory activity of C/EBPα by stabilizing C/EBPα-cdk2 and C/EBPα-Brm complexes. Mol Cell Biol. 2006;26:2570–82.
Chen SS, Chen JF, Johnson PF, Muppala V, Lee YH. C/EBPβ when expressed from the C/EBPα gene locus can functionally replace C/EBPα in liver but not adipose tissue. Mol Cell Biol. 2000;20:7292–9.
Linhart HG, Ishimura-Oka K, DeMayo F, et al. C/EBPα is required for differentiation of white but not brown adipose tissue. Proc Natl Acad Sci USA. 2001;98:12532–7.
Tamoir Y, Masugi J, Nishine N, Kasuga M. Role of peroxisome proliferator-activated receptor γ in maintenance of the characteristics of mature 3T3-l1 adipocytes. Diabetes. 2002;51:2045–55.
Meshorer E, Yellajoshula D, George E, et al. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell. 2006;10:105–16.
Bernstein BE, Mikkelson TS, Xie X, Kamal M, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125:315–25.
Bracken AP, Dietrich N, Pasini D, Hansen KH, et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123–36.
Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771–9.
Noer A, Sorensen AL, Boquet AC, Collas P. Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured and differentiated mesenchymal stem cells from adipose tissue. Mol Cell Biol. 2006;17:3543–56.
Melzner I, Scott V, Dorsch K, Fischer P, et al. Leptin gene expression in human preadipocytes is switched on by maturation-induced demethylation of distinct CpGs in its proximal promoter. J Biol Chem. 2002;277:45420–7.
Yokomori N, Tawata M, Onaya T. DNA demethylation during differentiation of the 3T3-L1 cells affects the expression of the mouse GLUT4 gene. Diabetes. 1999;48:685–90.
Yokomori N, Tawata M, Onaya T. DNA demethylation modulates mouse leptin promoter activity during differentiation of the 3T3-L1 cells. Diabetologia. 2002;45:140–8.
Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commiment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci USA. 2006;103:13022–7.
Salma N, Xiao H, Imbalzano AN. Temporal recruitment of C/EBPs to early and late adipogenic promoters in vivo. J Mol Endocrinol. 2006;36:139–51.
Salma N, Xiao H, Mueler E, Imbalzano AN. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the PPARγ nuclear hormone receptor. Mol Cell Biol. 2004;24:4651–63.
Zuo Y, Qiang L, Farmer SR. Activation of C/EBPα expression by C/EBPβ during adipogenesis requires a PPARγ-associated repression of HDAC1 at the C/EBPα gene promoter. J Biol Chem. 2006;281:7960–7.
Wiper-Bergeron N, Salem HA, Tomilson JJ, Wu D, Hache RJ. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5. Proc Natl Acad Sci USA. 2007;104:2703–8.
Johnson PF. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci. 2005;118:2545–55.
Mueller C, Calkhoven CF, Sha X, Leutz A. C/EBPα requires a SWI/SNF complex for proliferation arrest. J Biol Chem. 2004;279:7353–8.
Fajas L, Egler V, Reiter R, Hansen J, et al. The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation. Dev. Cell. 2002;3:903–10.
Chen Z, Johnson BA, Li Y, Aster S, et al. Both co-activators of LxxLL motif-dependent and independent interactions are required for PPARγ function. J Biol Chem. 2000;275:3733–6.
Takahashi N, Kawada T, Yamamoto T, et al. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CBP and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of PPARγ. J Biol Chem. 2002;277:16906–12.
Yu C, Markan K, Temple KA, et al. The nuclear receptor corepressors NCoR and SMRT decrease PPARγ transcriptional activity and repress 3T3-L1 adipogenesis. J Biol Chem. 2005;280:13600–5.
Gelman L, Zhou G, Fajas L, et al. p300 interacts with the N- and C-terminal part of PPARγ 2 in a ligand-independent and -dependent manner, respectively. J Biol Chem. 1999;274:7681–8.
Sarruf DA, Iankova I, Abella A, et al. Cyclin D3 promotes adipogenesis through activation of PPARγ. Mol Cell Biol. 2005;25:9985–95.
Fu M, Rao M, Bouras T, et al. Cyclin D1 inhibits PPARγ-mediated adipogenesis through histone deacetylase recruitment. Biol Chem. 2005;280:16934–41.
Huang L. Targeting histone deacetylases for treatment of cancer and inflammatory diseases. J Cell Physiol. 2006;209:611–6.
Yoo EJ, Chung JJ, Choe SS, et al. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem. 2006;281:6608–15.
Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPARγ. Nature. 2004;429:771–6.
Okada Y, Sakaue H, Nagare T, Kasuga M. Diet-induced up-regulation of gene expression in adipocytes without changes in DNA methylation. Kobe J Med Sci. 2008;54(5):E241–9.
Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today. 2009;14:942–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pinney, S.E., Simmons, R.A. (2011). Epigenetic Changes Associated with Intrauterine Growth Retardation and Adipogenesis. In: Lustig, R. (eds) Obesity Before Birth. Endocrine Updates, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7034-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7034-3_8
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7033-6
Online ISBN: 978-1-4419-7034-3
eBook Packages: MedicineMedicine (R0)